Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 1 of 20
Adapting Youth Nominated Support Team (YST) to Prevent Suicide
NCT07559955
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
NCT07433673
Decellularized Human Placental Extracellular Matrix Tissue for Rotator Cuff Repair Augmentation
NCT07027735
Effect of Insulin Lowering on Lipogenesis
NCT07403604
Topical TOR-582 Treatment of Epistaxis in HHT
NCT07667413
Multidimensional Sleep Health Intervention for Couples
NCT07603245
VibraCool Device to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)
NCT06456268
Spinal Cord Associative Plasticity in Cerebral Palsy
NCT07607665
The TAIL-PrEP Study
NCT06868641
TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome
NCT07541014
Cervical Spinal Cord Associative Plasticity
NCT07539025
In Vitro Fertilization (IVF) and Prenatal Effects Independent of Genetics
NCT07296107
guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing
NCT07610590
DELINEATE-Prospective
NCT07197736
An Effectiveness Trial of the PrEP for WINGS Study
NCT06853314
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
NCT06741618
Trial of Acceptance and Mindfulness-based Exposure Therapy (AMBET) and Present Centered Therapy (PCT)
NCT07410481
Impact of Barostimulation on Hemodynamics in Adults With Heart Failure
NCT07335510
HELIOS Advanced: Human Oocyte Illumination to Enhance Development
NCT07425080
A Multi-Level Strategy for De-implementing Mammography Overuse Among Older Women
NCT07511621
A Patient Activation Approach to Implementing Depression Treatment in Cardiac Patients
NCT07390331
Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening
NCT07195071
Structural Racism, Reward Related Decision Making and Substance Use Risk
NCT06221839
Digital Strategies to Advance Help-Seeking - Aim 3
NCT06774417
Cost Effective Air Filtration Intervention in Low-Income Housing to Reduce Asthma Morbidity
NCT07116460
CUIMC Focal Therapy Registry
NCT07623941
Impact of Pistachio Consumption on Sleep
NCT07218822
HELIOS: Human Embryo Illumination to Enhance Development
NCT07311928
IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study
NCT07217873
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
NCT06889168
Anxiety During Abstinence in AUD
NCT06793488
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
NCT07079735
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
NCT06571708
Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)
NCT06950983
Transcranial Direct Current Stimulation for Post Treatment Lyme Disease
NCT06915324
Oral Steroid Taper After Total Knee Arthroplasty
NCT07070882
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
NCT06145724
PiMZ Longitudinal Cohort (PiMZ Logic)
NCT06505603
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
NCT07015684
Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA
NCT06955897
R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
NCT06926894
Digital Strategies to Advance Help-Seeking Aim 1 and 2
NCT06774430
RFA for Superficial Lipomas
NCT06903208
Ending the Epidemic Interventions in the Dental Setting - UH3
NCT06890988
Effects of Ultra Processed Food on Intestinal Energy Harvest
NCT06853288
Discogen for Low Back Pain
NCT06611397
Improving Neck Control in Children With Cerebral Palsy Using Robotics
NCT06533293
Temporal Interference Stimulation for Social Cognition
NCT06607432
Moms and Babies Health and Well-being
NCT06923371
Ending the HIV Epidemic for Patient and Healthcare Staff Well-being
NCT05785169
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Columbia University pipeline card: 958 registered trials from official public datasets.Report a data error.